A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression-Reference-Cited by-同舟云学术

A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression

Published:2022-01 Issue:1 Volume:61 Page:46-55
ISSN:0890-8567
Container-title:Journal of the American Academy of Child & Adolescent Psychiatry
language:en
Short-container-title:Journal of the American Academy of Child & Adolescent Psychiatry

Author:

Vande Voort Jennifer L.^ORCID,Orth Scott S.^ORCID,Shekunov Julia^ORCID,Romanowicz Magdalena^ORCID,Geske Jennifer R.^ORCID,Ward Jessica A.^ORCID,Leibman Nicole I.^ORCID,Frye Mark A.^ORCID,Croarkin Paul E.^ORCID

Funder

Assurex Health

Mayo Clinic Center for Individualized Medicine

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Developmental and Educational Psychology

Reference43 articles.

1. Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment;Avenevoli;J Am Acad Child Adolesc Psychiatry,2015

2. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication−Adolescent Supplement (NCS-A);Merikangas;J Am Acad Child Adolesc Psychiatry,2010

3. Deaths: Leading causes for 2016;Heron;Natl Vital Stat Rep,2018

4. Antidepressant pharmacogenetics in children and young adults: a systematic review;Maruf;J Affect Disord,2019

5. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial;Brent;JAMA,2008

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug metabolizing enzymes pharmacogenetic variation-informed antidepressant therapy approach for common mental disorders: A systematic review and meta-analysis;Journal of Affective Disorders;2024-12

2. Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.;European Neuropsychopharmacology;2024-11

3. Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review;Therapeutic Drug Monitoring;2024-09-11

4. Exploring Youth-Perceived Barriers and Attitudes Towards the Clinical Use of Pharmacogenetic Testing to Optimise Antidepressant Pharmacotherapy;2024-08-26

5. Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial;Journal of Affective Disorders;2024-08